Abstract, published in Seizure
Purpose: Drug resistant epilepsy (DRE) affects approximately 30 percent of individuals with epilepsy worldwide. Surgery remains the most effective treatment for individuals with DRE, but referral to surgery is low and only about 60 percent of individuals who undergo surgery experience seizure control postoperatively. The present paper evaluates the evidence for using computational models in the prediction of surgical resection sites and surgical outcomes for patients with DRE.
Methods: We conducted a search in the Medline data base using the terms “refractory epilepsy”, “drug-resistant epilepsy”, “surgery”, “computational model”, and “artificial intelligence”. Inclusion: original articles in English and case reports from 2000 to 2020. Reviews were excluded.
Results: Clinical applications of computational models may lead to increased utilization of surgical services through improving our ability to predict outcomes and by improving surgical outcomes outright. The identification and optimization of nodes that are crucial for the genesis and propagation of epileptiform activity offers the most promising clinical applications of computational models discussed herein.
Conclusion: Advances in computational models may in the future significantly increase the application and efficacy of surgery for patients with drug resistant epilepsy by optimizing the site and amount of cortex to resect, but more research is needed before it achieves therapeutic utility.